This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Clinimix (2014-04-08)

Starting date:
April 8, 2014
Posting date:
April 23, 2014
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-39175

Recalled Products

Clinimix 

Reason

Particulate matter detected.

Depth of distribution

Hospitals in Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Quebec, Saskatchewan, Yukon, Prince Edward Island.

Affected products

Clinimix

DIN, NPN, DIN-HIM
DIN 02013967
Dosage form

Intravenous Solution

Strength
  • Dextrose - 16.6 g/100 mL
  • Glycine - 1.04 g/100 mL
  • Histidine - 220 mg/100 mL
  • L-Alanine - 1.04 g/100 mL
  • L-Arginine - 520 mg/100 mL
  • L-Isoleucine - 240 mg/100 mL
  • L-Leucine Hydrochloride - 310 mg /100 mL
  • L-Lysine Hydrochloride - 290 mg/100 mL
  • L-Methionine - 290 mg /100 mL
  • L-Phenylalanine Hydrochloride - 310 mg /100 mL
  • L-Proline - 210 mg /100 mL
  • L-Threonine - 210 mg /100 mL
  • L-Tyrosine - 20 mg /100 mL
  • L-Valine - 230 mg /100 mL
  • Magnesium Chloride - 51 mg /100 mL
  • Potassium Phosphate Dibasic - 261 mg /100 mL
  • Sodium Acetate - 340 mg /100 mL
  • Sodium Chloride - 58.5 mg /100 mL
  • Tryptophan- 90 mg /100 mL
Lot or serial number
  • W3K07C2
  • W3L04C2
  • W3L04C2S
Companies
Recalling Firm
Baxter Corporation
7125 Mississauga Rd.
Mississauga
L5N 0C2
Ontario
CANADA
Marketing Authorization Holder
Baxter Corporation
7125 Mississauga Rd.
Mississauga
L5N 0C2
Ontario
CANADA

Date modified: